Routine: IBDEI1XL

IBDEI1XL ; ; 04-FEB-2020

 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020

 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y

Q Q

 ;;^UTILITY(U,$J,358.3,30848,2)

 ;;=^5063033

 ;;^UTILITY(U,$J,358.3,30849,0)

 ;;=N17.0^^123^1596^3

 ;;^UTILITY(U,$J,358.3,30849,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,30849,1,3,0)

 ;;=3^AKI w/ Tubular Necrosis

 ;;^UTILITY(U,$J,358.3,30849,1,4,0)

 ;;=4^N17.0

 ;;^UTILITY(U,$J,358.3,30849,2)

 ;;=^5015598

 ;;^UTILITY(U,$J,358.3,30850,0)

 ;;=N17.1^^123^1596^1

 ;;^UTILITY(U,$J,358.3,30850,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,30850,1,3,0)

 ;;=3^AKI w/ Acute Cortical Necrosis

 ;;^UTILITY(U,$J,358.3,30850,1,4,0)

 ;;=4^N17.1

 ;;^UTILITY(U,$J,358.3,30850,2)

 ;;=^5015599

 ;;^UTILITY(U,$J,358.3,30851,0)

 ;;=N17.2^^123^1596^2

 ;;^UTILITY(U,$J,358.3,30851,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,30851,1,3,0)

 ;;=3^AKI w/ Medullary Necrosis

 ;;^UTILITY(U,$J,358.3,30851,1,4,0)

 ;;=4^N17.2

 ;;^UTILITY(U,$J,358.3,30851,2)

 ;;=^5015600

 ;;^UTILITY(U,$J,358.3,30852,0)

 ;;=N10.^^123^1596^6

 ;;^UTILITY(U,$J,358.3,30852,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,30852,1,3,0)

 ;;=3^Acute Tubulo-Interstitial Nephritis

 ;;^UTILITY(U,$J,358.3,30852,1,4,0)

 ;;=4^N10.

 ;;^UTILITY(U,$J,358.3,30852,2)

 ;;=^5015570

 ;;^UTILITY(U,$J,358.3,30853,0)

 ;;=N17.8^^123^1596^4

 ;;^UTILITY(U,$J,358.3,30853,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,30853,1,3,0)

 ;;=3^AKI,Other

 ;;^UTILITY(U,$J,358.3,30853,1,4,0)

 ;;=4^N17.8

 ;;^UTILITY(U,$J,358.3,30853,2)

 ;;=^5015601

 ;;^UTILITY(U,$J,358.3,30854,0)

 ;;=N17.9^^123^1596^5

 ;;^UTILITY(U,$J,358.3,30854,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,30854,1,3,0)

 ;;=3^AKI,Unspec

 ;;^UTILITY(U,$J,358.3,30854,1,4,0)

 ;;=4^N17.9

 ;;^UTILITY(U,$J,358.3,30854,2)

 ;;=^338532

 ;;^UTILITY(U,$J,358.3,30855,0)

 ;;=R39.2^^123^1596^15

 ;;^UTILITY(U,$J,358.3,30855,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,30855,1,3,0)

 ;;=3^Pre-Renal Uremia

 ;;^UTILITY(U,$J,358.3,30855,1,4,0)

 ;;=4^R39.2

 ;;^UTILITY(U,$J,358.3,30855,2)

 ;;=^5019348

 ;;^UTILITY(U,$J,358.3,30856,0)

 ;;=N13.9^^123^1596^14

 ;;^UTILITY(U,$J,358.3,30856,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,30856,1,3,0)

 ;;=3^Obstructive and Reflux Uropathy,Unspec

 ;;^UTILITY(U,$J,358.3,30856,1,4,0)

 ;;=4^N13.9

 ;;^UTILITY(U,$J,358.3,30856,2)

 ;;=^5015589

 ;;^UTILITY(U,$J,358.3,30857,0)

 ;;=N13.1^^123^1596^11

 ;;^UTILITY(U,$J,358.3,30857,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,30857,1,3,0)

 ;;=3^Hydronephrosis w/ Ureteral Stricture NEC

 ;;^UTILITY(U,$J,358.3,30857,1,4,0)

 ;;=4^N13.1

 ;;^UTILITY(U,$J,358.3,30857,2)

 ;;=^5015576

 ;;^UTILITY(U,$J,358.3,30858,0)

 ;;=N13.2^^123^1596^10

 ;;^UTILITY(U,$J,358.3,30858,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,30858,1,3,0)

 ;;=3^Hydronephrosis w/ Renal and Ureteral Calculous Obstruction

 ;;^UTILITY(U,$J,358.3,30858,1,4,0)

 ;;=4^N13.2

 ;;^UTILITY(U,$J,358.3,30858,2)

 ;;=^5015577

 ;;^UTILITY(U,$J,358.3,30859,0)

 ;;=N13.30^^123^1596^13

 ;;^UTILITY(U,$J,358.3,30859,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,30859,1,3,0)

 ;;=3^Hydronephrosis,Unspec

 ;;^UTILITY(U,$J,358.3,30859,1,4,0)

 ;;=4^N13.30

 ;;^UTILITY(U,$J,358.3,30859,2)

 ;;=^5015578

 ;;^UTILITY(U,$J,358.3,30860,0)

 ;;=N13.39^^123^1596^12

 ;;^UTILITY(U,$J,358.3,30860,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,30860,1,3,0)

 ;;=3^Hydronephrosis,Other

 ;;^UTILITY(U,$J,358.3,30860,1,4,0)

 ;;=4^N13.39

 ;;^UTILITY(U,$J,358.3,30860,2)

 ;;=^5015579

 ;;^UTILITY(U,$J,358.3,30861,0)

 ;;=R33.9^^123^1596^16

 ;;^UTILITY(U,$J,358.3,30861,1,0)

 ;;=^358.31IA^4^2

--- Routine Detail   --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI1XL   3770     printed  Feb 18, 2025@23:44:07                                                                                                                                                                                                    Page 2

IBDEI1XL  ; ; 04-FEB-2020

 +1       ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020

 +2        if 'DIFQR(358.3)

               QUIT

           FOR I=1:2

               SET X=$TEXT(Q+I)

               if X=""

                   QUIT

               SET Y=$EXTRACT($TEXT(Q+I+1),4,999)

               SET X=$EXTRACT(X,4,999)

               if $ASCII(Y)=126

                   SET I=I+1

                   SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)

               if $ASCII(Y)=61

                   SET Y=$EXTRACT(Y,2,999)

               XECUTE NO

              IF '$TEST

                   SET @X=Y

Q          QUIT

 +1       ;;^UTILITY(U,$J,358.3,30848,2)

 +2       ;;=^5063033

 +3       ;;^UTILITY(U,$J,358.3,30849,0)

 +4       ;;=N17.0^^123^1596^3

 +5       ;;^UTILITY(U,$J,358.3,30849,1,0)

 +6       ;;=^358.31IA^4^2

 +7       ;;^UTILITY(U,$J,358.3,30849,1,3,0)

 +8       ;;=3^AKI w/ Tubular Necrosis

 +9       ;;^UTILITY(U,$J,358.3,30849,1,4,0)

 +10      ;;=4^N17.0

 +11      ;;^UTILITY(U,$J,358.3,30849,2)

 +12      ;;=^5015598

 +13      ;;^UTILITY(U,$J,358.3,30850,0)

 +14      ;;=N17.1^^123^1596^1

 +15      ;;^UTILITY(U,$J,358.3,30850,1,0)

 +16      ;;=^358.31IA^4^2

 +17      ;;^UTILITY(U,$J,358.3,30850,1,3,0)

 +18      ;;=3^AKI w/ Acute Cortical Necrosis

 +19      ;;^UTILITY(U,$J,358.3,30850,1,4,0)

 +20      ;;=4^N17.1

 +21      ;;^UTILITY(U,$J,358.3,30850,2)

 +22      ;;=^5015599

 +23      ;;^UTILITY(U,$J,358.3,30851,0)

 +24      ;;=N17.2^^123^1596^2

 +25      ;;^UTILITY(U,$J,358.3,30851,1,0)

 +26      ;;=^358.31IA^4^2

 +27      ;;^UTILITY(U,$J,358.3,30851,1,3,0)

 +28      ;;=3^AKI w/ Medullary Necrosis

 +29      ;;^UTILITY(U,$J,358.3,30851,1,4,0)

 +30      ;;=4^N17.2

 +31      ;;^UTILITY(U,$J,358.3,30851,2)

 +32      ;;=^5015600

 +33      ;;^UTILITY(U,$J,358.3,30852,0)

 +34      ;;=N10.^^123^1596^6

 +35      ;;^UTILITY(U,$J,358.3,30852,1,0)

 +36      ;;=^358.31IA^4^2

 +37      ;;^UTILITY(U,$J,358.3,30852,1,3,0)

 +38      ;;=3^Acute Tubulo-Interstitial Nephritis

 +39      ;;^UTILITY(U,$J,358.3,30852,1,4,0)

 +40      ;;=4^N10.

 +41      ;;^UTILITY(U,$J,358.3,30852,2)

 +42      ;;=^5015570

 +43      ;;^UTILITY(U,$J,358.3,30853,0)

 +44      ;;=N17.8^^123^1596^4

 +45      ;;^UTILITY(U,$J,358.3,30853,1,0)

 +46      ;;=^358.31IA^4^2

 +47      ;;^UTILITY(U,$J,358.3,30853,1,3,0)

 +48      ;;=3^AKI,Other

 +49      ;;^UTILITY(U,$J,358.3,30853,1,4,0)

 +50      ;;=4^N17.8

 +51      ;;^UTILITY(U,$J,358.3,30853,2)

 +52      ;;=^5015601

 +53      ;;^UTILITY(U,$J,358.3,30854,0)

 +54      ;;=N17.9^^123^1596^5

 +55      ;;^UTILITY(U,$J,358.3,30854,1,0)

 +56      ;;=^358.31IA^4^2

 +57      ;;^UTILITY(U,$J,358.3,30854,1,3,0)

 +58      ;;=3^AKI,Unspec

 +59      ;;^UTILITY(U,$J,358.3,30854,1,4,0)

 +60      ;;=4^N17.9

 +61      ;;^UTILITY(U,$J,358.3,30854,2)

 +62      ;;=^338532

 +63      ;;^UTILITY(U,$J,358.3,30855,0)

 +64      ;;=R39.2^^123^1596^15

 +65      ;;^UTILITY(U,$J,358.3,30855,1,0)

 +66      ;;=^358.31IA^4^2

 +67      ;;^UTILITY(U,$J,358.3,30855,1,3,0)

 +68      ;;=3^Pre-Renal Uremia

 +69      ;;^UTILITY(U,$J,358.3,30855,1,4,0)

 +70      ;;=4^R39.2

 +71      ;;^UTILITY(U,$J,358.3,30855,2)

 +72      ;;=^5019348

 +73      ;;^UTILITY(U,$J,358.3,30856,0)

 +74      ;;=N13.9^^123^1596^14

 +75      ;;^UTILITY(U,$J,358.3,30856,1,0)

 +76      ;;=^358.31IA^4^2

 +77      ;;^UTILITY(U,$J,358.3,30856,1,3,0)

 +78      ;;=3^Obstructive and Reflux Uropathy,Unspec

 +79      ;;^UTILITY(U,$J,358.3,30856,1,4,0)

 +80      ;;=4^N13.9

 +81      ;;^UTILITY(U,$J,358.3,30856,2)

 +82      ;;=^5015589

 +83      ;;^UTILITY(U,$J,358.3,30857,0)

 +84      ;;=N13.1^^123^1596^11

 +85      ;;^UTILITY(U,$J,358.3,30857,1,0)

 +86      ;;=^358.31IA^4^2

 +87      ;;^UTILITY(U,$J,358.3,30857,1,3,0)

 +88      ;;=3^Hydronephrosis w/ Ureteral Stricture NEC

 +89      ;;^UTILITY(U,$J,358.3,30857,1,4,0)

 +90      ;;=4^N13.1

 +91      ;;^UTILITY(U,$J,358.3,30857,2)

 +92      ;;=^5015576

 +93      ;;^UTILITY(U,$J,358.3,30858,0)

 +94      ;;=N13.2^^123^1596^10

 +95      ;;^UTILITY(U,$J,358.3,30858,1,0)

 +96      ;;=^358.31IA^4^2

 +97      ;;^UTILITY(U,$J,358.3,30858,1,3,0)

 +98      ;;=3^Hydronephrosis w/ Renal and Ureteral Calculous Obstruction

 +99      ;;^UTILITY(U,$J,358.3,30858,1,4,0)

 +100     ;;=4^N13.2

 +101     ;;^UTILITY(U,$J,358.3,30858,2)

 +102     ;;=^5015577

 +103     ;;^UTILITY(U,$J,358.3,30859,0)

 +104     ;;=N13.30^^123^1596^13

 +105     ;;^UTILITY(U,$J,358.3,30859,1,0)

 +106     ;;=^358.31IA^4^2

 +107     ;;^UTILITY(U,$J,358.3,30859,1,3,0)

 +108     ;;=3^Hydronephrosis,Unspec

 +109     ;;^UTILITY(U,$J,358.3,30859,1,4,0)

 +110     ;;=4^N13.30

 +111     ;;^UTILITY(U,$J,358.3,30859,2)

 +112     ;;=^5015578

 +113     ;;^UTILITY(U,$J,358.3,30860,0)

 +114     ;;=N13.39^^123^1596^12

 +115     ;;^UTILITY(U,$J,358.3,30860,1,0)

 +116     ;;=^358.31IA^4^2

 +117     ;;^UTILITY(U,$J,358.3,30860,1,3,0)

 +118     ;;=3^Hydronephrosis,Other

 +119     ;;^UTILITY(U,$J,358.3,30860,1,4,0)

 +120     ;;=4^N13.39

 +121     ;;^UTILITY(U,$J,358.3,30860,2)

 +122     ;;=^5015579

 +123     ;;^UTILITY(U,$J,358.3,30861,0)

 +124     ;;=R33.9^^123^1596^16

 +125     ;;^UTILITY(U,$J,358.3,30861,1,0)

 +126     ;;=^358.31IA^4^2

IBDEI1XL.m